Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis

Intravenous leiomyomatosis (IVLM) is a rare benign smooth muscle tumour that is characterised by intravenous growth in the uterine and pelvic veins. Previous DNA copy number and transcriptomic studies have shown that IVLM harbors unique genomic and transcriptomic alterations when compared to uterine...

Full description

Bibliographic Details
Main Authors: Lukas Krasny, Chris P. Wilding, Emma Perkins, Amani Arthur, Nafia Guljar, Andrew D. Jenks, Cyril Fisher, Ian Judson, Khin Thway, Robin L. Jones, Paul H. Huang
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/12/2907
_version_ 1797489220855529472
author Lukas Krasny
Chris P. Wilding
Emma Perkins
Amani Arthur
Nafia Guljar
Andrew D. Jenks
Cyril Fisher
Ian Judson
Khin Thway
Robin L. Jones
Paul H. Huang
author_facet Lukas Krasny
Chris P. Wilding
Emma Perkins
Amani Arthur
Nafia Guljar
Andrew D. Jenks
Cyril Fisher
Ian Judson
Khin Thway
Robin L. Jones
Paul H. Huang
author_sort Lukas Krasny
collection DOAJ
description Intravenous leiomyomatosis (IVLM) is a rare benign smooth muscle tumour that is characterised by intravenous growth in the uterine and pelvic veins. Previous DNA copy number and transcriptomic studies have shown that IVLM harbors unique genomic and transcriptomic alterations when compared to uterine leiomyoma (uLM), which may account for their distinct clinical behaviour. Here we undertake the first comparative proteomic analysis of IVLM and other smooth muscle tumours (comprising uLM, soft tissue leiomyoma and benign metastasizing leiomyoma) utilising data-independent acquisition mass spectrometry. We show that, at the protein level, IVLM is defined by the unique co-regulated expression of splicing factors. In particular, IVLM is enriched in two clusters composed of co-regulated proteins from the hnRNP, LSm, SR and Sm classes of the spliceosome complex. One of these clusters (Cluster 3) is associated with key biological processes including nascent protein translocation and cell signalling by small GTPases. Taken together, our study provides evidence of co-regulated expression of splicing factors in IVLM compared to other smooth muscle tumours, which suggests a possible role for alternative splicing in the pathogenesis of IVLM.
first_indexed 2024-03-10T00:13:23Z
format Article
id doaj.art-c02fac6476b3411081c629d83883a382
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T00:13:23Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-c02fac6476b3411081c629d83883a3822023-11-23T15:56:13ZengMDPI AGCancers2072-66942022-06-011412290710.3390/cancers14122907Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous LeiomyomatosisLukas Krasny0Chris P. Wilding1Emma Perkins2Amani Arthur3Nafia Guljar4Andrew D. Jenks5Cyril Fisher6Ian Judson7Khin Thway8Robin L. Jones9Paul H. Huang10Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham B15 2GW, UKThe Royal Marsden NHS Foundation Trust, London SW3 6JJ, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKThe Royal Marsden NHS Foundation Trust, London SW3 6JJ, UKDivision of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UKIntravenous leiomyomatosis (IVLM) is a rare benign smooth muscle tumour that is characterised by intravenous growth in the uterine and pelvic veins. Previous DNA copy number and transcriptomic studies have shown that IVLM harbors unique genomic and transcriptomic alterations when compared to uterine leiomyoma (uLM), which may account for their distinct clinical behaviour. Here we undertake the first comparative proteomic analysis of IVLM and other smooth muscle tumours (comprising uLM, soft tissue leiomyoma and benign metastasizing leiomyoma) utilising data-independent acquisition mass spectrometry. We show that, at the protein level, IVLM is defined by the unique co-regulated expression of splicing factors. In particular, IVLM is enriched in two clusters composed of co-regulated proteins from the hnRNP, LSm, SR and Sm classes of the spliceosome complex. One of these clusters (Cluster 3) is associated with key biological processes including nascent protein translocation and cell signalling by small GTPases. Taken together, our study provides evidence of co-regulated expression of splicing factors in IVLM compared to other smooth muscle tumours, which suggests a possible role for alternative splicing in the pathogenesis of IVLM.https://www.mdpi.com/2072-6694/14/12/2907proteomicsspliceosomesplicing factorsleiomyomaintravenous leiomyomatosis
spellingShingle Lukas Krasny
Chris P. Wilding
Emma Perkins
Amani Arthur
Nafia Guljar
Andrew D. Jenks
Cyril Fisher
Ian Judson
Khin Thway
Robin L. Jones
Paul H. Huang
Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
Cancers
proteomics
spliceosome
splicing factors
leiomyoma
intravenous leiomyomatosis
title Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
title_full Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
title_fullStr Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
title_full_unstemmed Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
title_short Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis
title_sort proteomic profiling identifies co regulated expression of splicing factors as a characteristic feature of intravenous leiomyomatosis
topic proteomics
spliceosome
splicing factors
leiomyoma
intravenous leiomyomatosis
url https://www.mdpi.com/2072-6694/14/12/2907
work_keys_str_mv AT lukaskrasny proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT chrispwilding proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT emmaperkins proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT amaniarthur proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT nafiaguljar proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT andrewdjenks proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT cyrilfisher proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT ianjudson proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT khinthway proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT robinljones proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis
AT paulhhuang proteomicprofilingidentifiescoregulatedexpressionofsplicingfactorsasacharacteristicfeatureofintravenousleiomyomatosis